Suppression of myoclonus in SCA2by Piracetam

Anna De Rosa, Pasquale Striano, Fabrizio Barbieri, Arturo de Faco, Carlo Rinaldi, Tecla Tucci, Salvatore Striano, Alessandro Filla, Giuseppe De Michele

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.

Original languageEnglish
Pages (from-to)116-118
Number of pages3
JournalMovement Disorders
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Piracetam
Myoclonus
Spinocerebellar Degenerations
Therapeutics

Keywords

  • Myoclunus
  • Nootropic drugs
  • Piracetam
  • SCA2

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

De Rosa, A., Striano, P., Barbieri, F., de Faco, A., Rinaldi, C., Tucci, T., ... De Michele, G. (2006). Suppression of myoclonus in SCA2by Piracetam. Movement Disorders, 21(1), 116-118. https://doi.org/10.1002/mds.20683

Suppression of myoclonus in SCA2by Piracetam. / De Rosa, Anna; Striano, Pasquale; Barbieri, Fabrizio; de Faco, Arturo; Rinaldi, Carlo; Tucci, Tecla; Striano, Salvatore; Filla, Alessandro; De Michele, Giuseppe.

In: Movement Disorders, Vol. 21, No. 1, 01.2006, p. 116-118.

Research output: Contribution to journalArticle

De Rosa, A, Striano, P, Barbieri, F, de Faco, A, Rinaldi, C, Tucci, T, Striano, S, Filla, A & De Michele, G 2006, 'Suppression of myoclonus in SCA2by Piracetam', Movement Disorders, vol. 21, no. 1, pp. 116-118. https://doi.org/10.1002/mds.20683
De Rosa A, Striano P, Barbieri F, de Faco A, Rinaldi C, Tucci T et al. Suppression of myoclonus in SCA2by Piracetam. Movement Disorders. 2006 Jan;21(1):116-118. https://doi.org/10.1002/mds.20683
De Rosa, Anna ; Striano, Pasquale ; Barbieri, Fabrizio ; de Faco, Arturo ; Rinaldi, Carlo ; Tucci, Tecla ; Striano, Salvatore ; Filla, Alessandro ; De Michele, Giuseppe. / Suppression of myoclonus in SCA2by Piracetam. In: Movement Disorders. 2006 ; Vol. 21, No. 1. pp. 116-118.
@article{a1abff0e7da044eda2d471f248ebb4cb,
title = "Suppression of myoclonus in SCA2by Piracetam",
abstract = "We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.",
keywords = "Myoclunus, Nootropic drugs, Piracetam, SCA2",
author = "{De Rosa}, Anna and Pasquale Striano and Fabrizio Barbieri and {de Faco}, Arturo and Carlo Rinaldi and Tecla Tucci and Salvatore Striano and Alessandro Filla and {De Michele}, Giuseppe",
year = "2006",
month = "1",
doi = "10.1002/mds.20683",
language = "English",
volume = "21",
pages = "116--118",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Suppression of myoclonus in SCA2by Piracetam

AU - De Rosa, Anna

AU - Striano, Pasquale

AU - Barbieri, Fabrizio

AU - de Faco, Arturo

AU - Rinaldi, Carlo

AU - Tucci, Tecla

AU - Striano, Salvatore

AU - Filla, Alessandro

AU - De Michele, Giuseppe

PY - 2006/1

Y1 - 2006/1

N2 - We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.

AB - We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.

KW - Myoclunus

KW - Nootropic drugs

KW - Piracetam

KW - SCA2

UR - http://www.scopus.com/inward/record.url?scp=33244476269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244476269&partnerID=8YFLogxK

U2 - 10.1002/mds.20683

DO - 10.1002/mds.20683

M3 - Article

VL - 21

SP - 116

EP - 118

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 1

ER -